<DOC>
	<DOCNO>NCT00589628</DOCNO>
	<brief_summary>The primary objective study examine efficacy infliximab treatment persistent uveitis child . Participants ( 4-18 year age ) randomly assign either 5mg/kg 10mg/kg dose infliximab administer intravenous infusion four week interval . Participant response measure four eight week interval ten month .</brief_summary>
	<brief_title>Multi Center Prospective Registry Infliximab Use Childhood Uveitis</brief_title>
	<detailed_description>Pediatric rheumatologist often use infliximab treatment childhood uveitis , time prospective study use . Participants randomize initial suggest dose infliximab ( 5 mg/kg/dose vs 10 mg/kg/dose ) data collect prospectively regard ophthalmologic outcome . Study participant follow 10 month determine efficacy side effect , additional 30 day safety report . Descriptive statistic gather participant demographic , uveitis characteristic , change immunosuppressive medication , number responder , ophthalmologic measure change corticosteroid dose study period . Initial final dose examine paired t-test . The proportion responders 5 mg/kg initial dose group compare 10 mg/kg/dose Chi-square Fisher 's exact test , depend number available . Predictors response examine logistic regression .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>. 1 . Ages 4 18 year old , 2 . Noninfectious uveitis 3 . Persistent uveitis uncontrolled topical medication , unacceptable side effect topical medication . 4 . Failure least six week treatment nonbiological disease modify agent methotrexate , cyclosporine , mycophenolate mofetil , azathioprine . 5 . Ability provide inform consent ( subject parent/guardian ) 6 . Onset uveitis &lt; 16 year age . 7 . Topical ophthalmologic treatment allow . 8 . Systemic corticosteroid use entry may allow . 9 . Willingness use acceptable contraception sexually active duration study 6 month receive last infliximab infusion . 10 . Concomitant methotrexate must take time initiation infliximab 11 . Participant must able cooperate nonsedated slit lamp exam visual acuity examination . 12 . Negative Purified Protein Derivative ( PPD ) place read within 1 month initiation infliximab 13 . The screen laboratory test result must meet following criterion : WBC ( white blood cell count ) : within normal range institution ANC ( absolute neutrophil count ) : within normal range institution Hemoglobin : great 10 grams/deciliter Platelets : within normal range institution Serum Creatinine : within normal range age AST aspartate aminotransferase within normal range institution ALT alanine aminotransferase within normal range institution 1 . Previous use biologic medication uveitis . 2 . Intraocular steroid injection ophthalmologic surgery within precede 3 month . 3 . Uveitis due trauma intraocular surgery 4 . Females pregnant , nursing , plan pregnancy within 6 month last infliximab infusion . 5 . Males plan father child within 6 month last infliximab infusion . 6 . A history know allergy murine product . 7 . Documentation seropositivity human immunodeficiency virus ( HIV ) . 8 . Documentation positive test hepatitis B surface antigen hepatitis C 9 . A known history serious infection ( e.g. , hepatitis , pneumonia , pyelonephritis ) previous 3 month . 10 . An opportunistic infection ( e.g. , herpes zoster [ shingle ] , cytomegalovirus , Pneumocystis carinii , aspergillosis , histoplasmosis , mycobacteria TB ) within 6 month prior screen . 11 . A concomitant diagnosis history congestive heart failure . 12 . A history lymphoproliferative disease . 13 . Any known malignancy history malignancy . 14 . Current sign symptom severe , progressive uncontrolled renal , hepatic , hematologic , gastrointestinal , endocrine , pulmonary , cardiac , neurologic , cerebral disease . 15 . Use investigational drug within 30 day prior screen within five halflives first dose investigational agent , whichever longer . 16 . Presence transplant solid organ .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Childhood</keyword>
	<keyword>Uveitis</keyword>
</DOC>